浏览全部资源
扫码关注微信
熊果酸对IL-6介导的乳腺癌细胞侵袭与迁移的抑制作用
Inhibitory effects of ursolic acid on IL-6-mediated invasion and migration of breast cancer cells
- 中国药房 2023年34卷第8期 页码：955-960
- 作者机构：
上海中医药大学附属普陀医院检验科，上海 200062
- 作者简介：
硕士研究生。研究方向：中药逆转肿瘤侵袭与转移的分子机制。E-mail：1064417934@qq.com
主任技师，硕士生导师。研究方向：中药逆转肿瘤侵袭与转移的分子机制。E-mail：rong701@126.com
- 基金信息：上海市“医苑新星”青年医学人才培养资助计划项目(沪卫计人事〔2019〕72号);上海市普陀区卫生健康系统科技创新项目(ptkwws202307);上海市普陀区中心医院科研启航计划项目(2022-RCQH-03)
DOI：10.6039/j.issn.1001-0408.2023.08.12
中图分类号： R965纸质出版日期：2023-04-30，
收稿日期：2022-11-10，
修回日期：2023-02-17，
扫 描 看 全 文
刘荣荣,张涛,相芬芬等.熊果酸对IL-6介导的乳腺癌细胞侵袭与迁移的抑制作用 Δ[J].中国药房,2023,34(08):955-960.
LIU Rongrong,ZHANG Tao,XIANG Fenfen,et al.Inhibitory effects of ursolic acid on IL-6-mediated invasion and migration of breast cancer cells[J].ZHONGGUO YAOFANG,2023,34(08):955-960.
刘荣荣,张涛,相芬芬等.熊果酸对IL-6介导的乳腺癌细胞侵袭与迁移的抑制作用 Δ[J].中国药房,2023,34(08):955-960. DOI： 10.6039/j.issn.1001-0408.2023.08.12.
LIU Rongrong,ZHANG Tao,XIANG Fenfen,et al.Inhibitory effects of ursolic acid on IL-6-mediated invasion and migration of breast cancer cells[J].ZHONGGUO YAOFANG,2023,34(08):955-960. DOI： 10.6039/j.issn.1001-0408.2023.08.12.
摘要
目的
2
探讨熊果酸对白细胞介素6（IL-6）介导的乳腺癌MDA-MB-231细胞（简称“231细胞”）的侵袭与迁移的抑制作用。
方法
2
采用CCK-8法检测20、40、80、160、320 µmol/L熊果酸对231细胞增殖率的影响。将细胞分为对照组、模型组和给药组，划痕实验与Transwell实验检测细胞的迁移能力与侵袭能力；实时荧光定量聚合酶链式反应（q-PCR）法与Western blot法检测细胞上皮间质转化相关标志物E钙黏蛋白（E-cad）、基质金属蛋白酶2（MMP2）、MMP9、波形蛋白（Vim）、CD44分子（CD44）、醛脱氢酶1家族成员A1（ALDH1A1）mRNA与蛋白的相对表达情况；Western blot法检测Janus激酶2/信号转导及转录激活因子3（JAK2/STAT3）通路中JAK2、STAT3的磷酸化水平[以磷酸化JAK2（p-JAK2）/JAK2比值、磷酸化STAT3（p-STAT3）/STAT3比值计]。
结果
2
实验选取熊果酸低浓度20 µmol/L（对细胞增殖能力无明显抑制作用）作为后续给药浓度。与对照组比较，模型组细胞的迁移、侵袭能力均显著增强（
P
＜0.05）；与模型组比较，给药组细胞的迁移、侵袭能力均显著降低（
P
＜0.05）。与对照组比较，模型组细胞中上皮间质转化相关标志物MMP9、MMP2、Vim、ALDH1A1、CD44 mRNA与蛋白的相对表达量均有不同程度的升高，E-cad mRNA与蛋白的相对表达量均有不同程度的降低，部分差异有统计学意义（
P
＜0.05），p-JAK2/JAK2比值、p-STAT3/STAT3比值均显著升高（
P
＜0.05）；与模型组比较，给药组细胞中上述指标的表达均有一定程度逆转。
结论
2
熊果酸通过阻断JAK2/STAT3信号通路的激活进而抑制炎症因子IL-6诱导的上皮间质转化过程，最终抑制乳腺癌细胞的侵袭、迁移。
Abstract
OBJECTIVE
2
To investigate the inhibitory effects of ursolic acid on interleukin-6 （IL-6）-mediated invasion and migration of breast cancer MDA-MB-231 cells （hereinafter referred to as “231 cells”）.
METHODS
2
The effects of 20， 40， 80， 160 and 320 µmol/L ursolic acid on the proliferation rate of 231 cells were measured by CCK-8 method. The breast cancer 231 cells were divided into control group， model group and administration group. The migration and invasion abilities of cells were detected by scratch assay and Transwell assay. Real-time quantitative polymerase chain reaction （q-PCR） assay and Western blot assay were used to detect the mRNA and protein expressions of epithelial-mesenchymal transition-related makers such as E cadherin （E-cad）， matrix metalloprotein 2 （MMP2）， MMP9， vimentin （Vim）， CD44 molecule （CD44） and aldehyde dehydrogenase 1 family member A1 （ALDH1A1）. The phosphorylation levels of JAK2 and STAT3 in the Janus kinase 2/signal transducer and activator of transcription 3 （JAK2/STAT3） signaling pathway （in terms of p-JAK2/JAK2 ratio and p-STAT3/STAT3 ratio） were detected by Western blot assay.
RESULTS
2
A low concentration of ursolic acid of 20 µmol/L （no significant inhibitory effect on cell proliferation ability） was selected as the subsequent administration concentration. Compared with the control group， the migration and invasion abilities of cells in the model group were significantly enhanced （
P
＜0.05）； compared with the model group， the migration and invasion abilities of cells in the administered group were significantly reduced （
P
＜0.05）. Compared with the control group， the relative mRNA and protein expressions of epithelial-mesenchymal transition-related markers MMP9， MMP2， Vim， ALDH1A1 and CD44 were all elevated to different extents， and the mRNA and protein expressions of E-cad were all decreased to different extents in the model group cells， and part of the differences had statistical significance （
P
＜0.05）， the p-JAK2/JAK2 ratio and p-STAT3/STAT3 ratio were significantly increased in the model group （
P
＜0.05）； compared with the model group， the expressions of the above indicators were reversed to some extent in the administration group.
CONCLUSIONS
2
Ursolic acid blocks the activation of JAK2/STAT3 signaling pathway and thus inhibits the epithelial-mesenchymal transition induced by the inflammatory factor IL-6， which ultimately interrupts the invasion and metastasis of breast cancer cells.
关键词
熊果酸白细胞介素6乳腺癌Janus激酶2/信号转导及转录激活因子3通路侵袭迁移
Keywords
IL-6breast cancerJAK2/STAT3 pathwayinvasionmigration
references
SUNG H，FERLAY J，SIEGEL R L，et al. Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin，2021，71（3）：209-249.
ELISHA Y，SAGI Y，KLEIN G，et al. Cooperativity between stromal cytokines drives the invasive migration of human breast cancer cells[J]. Philos Trans R Soc Lond B Biol Sci，2019，374（1779）：20180231.
FENG X，XUE F，HE G H，et al. Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regu-lating MGMT expression via IL-6/JAK/STAT3-mediated PD-L1 activity[J]. Int J Mol Med，2021，48（2）：165.
IQBAL J，ABBASI B A，AHMAD R，et al. Ursolic acid a promising candidate in the therapeutics of breast cancer：current status and future implications[J]. Biomed Pharmacother，2018，108：752-756.
YANG K Y，CHEN Y，ZHOU J Q，et al. Ursolic acid promotes apoptosis and mediates transcriptional suppression of CT45A2 gene expression in non-small-cell lung carcinoma harbouring EGFR T790M mutations[J]. Br J Pharmacol，2019，176（24）：4609-4624.
KIM S H，JIN H，MENG R Y，et al. Activating hippo pathway via Rassf1 by ursolic acid suppresses the tumorigenesis of gastric cancer[J]. Int J Mol Sci，2019，20（19）：4709.
ZHAO R R，FANG Y F，CHEN Z X. Self-assembled amphiphile-based nanoparticles for the inhibition of hepatocellular carcinoma metastasis via ICAM-1 mediated cell adhesion[J]. Acta Biomater，2020，111：373-385.
李龙龙，刘琪，张光强，等. 熊果酸对乳腺癌MCF-7细胞生长抑制作用机制探讨[J]. 中华肿瘤防治杂志，2020，27（9）：692-697.
ZHANG X，LI T，GONG E S，et al. Antiproliferative activity of ursolic acid in MDA-MB-231 human breast cancer cells through Nrf2 pathway regulation[J]. J Agric Food Chem，2020，68（28）：7404-7415.
JIANG X，LI T，LIU R H. 2α-hydroxyursolic acid inhi-bited cell proliferation and induced apoptosis in MDA-MB-231 human breast cancer cells through the p38/MAPK signal transduction pathway[J]. J Agric Food Chem，2016，64（8）：1806-1816.
ZHANG Y B，MA X R，LI H Y，et al. Identifying the effect of ursolic acid against triple-negative breast cancer：coupling network pharmacology with experiments verification[J]. Front Pharmacol，2021，12：685773.
XIANG F F，FAN Y，NI Z H，et al. Ursolic acid reverses the chemoresistance of breast cancer cells to paclitaxel by targeting MiRNA-149-5p/MyD88[J]. Front Oncol，2019，9：501.
吴大平，吴焕良，郑文宏，等. IL-6调控miR-204及Notch1促进乳腺癌细胞增殖、迁移和侵袭[J]. 现代免疫学，2021，41（5）：380-385，406.
MILOVANOVIĆ J，TODOROVIĆ-RAKOVIĆ N，RADULOVIC M. Interleukin-6 and interleukin-8 serum levels in prognosis of hormone-dependent breast cancer[J]. Cytokine，2019，118：93-98.
YOU Y H，TIAN Z W，DU Z，et al. M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/STAT3/THBS1 feedback loop[J]. J Exp Clin Cancer Res，2022，41（1）：10.
JING B，WANG T，SUN B B，et al. IL6/STAT3 signaling orchestrates premetastatic niche formation and immunosuppressive traits in lung[J]. Cancer Res，2020，80（4）：784-797.
HUANG Y H，HONG W Q，WEI X W. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis[J]. J Hematol Oncol，2022，15（1）：129.
BRITT K L，CUZICK J，PHILLIPS K A. Key steps for effective breast cancer prevention[J]. Nat Rev Cancer，2020，20（8）：417-436.
PARK M，KIM D，KO S，et al. Breast cancer metastasis：mechanisms and therapeutic implications[J]. Int J Mol Sci，2022，23（12）：6806.
0
浏览量
1
下载量
0
CSCD
- 网络PDF下载
- WORD下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 地址：重庆市渝中区大坪正街129号四环大厦8层 400042
- 技术支持由北京北大方正电子有限公司提供 渝ICP备15012710号
公网安备50010302001817 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies